Would you offer adjuvant chemotherapy for MSI-H Stage II colon cancer with multiple high risk features?
eg LVI/PNI, poorly differentiated? If so, what regimen and for how long?
Answer from: Medical Oncologist at Academic Institution
About 15-20% of colorectal cancers are found to be MSI-high. These tumors are generally associated with a superior prognosis to those who are MSI-stable. Thus, the question as to whether one should utilize adjuvant chemotherapy in the context of patients with stage II disease, a setting where adjuva...
Comments
Medical Oncologist at Intermountain Medical Center I don't disagree with @Alfred I. Neugut but I do t...
Medical Oncologist at Harvard Medical School I entirely agree with @Mark A. Lewis's comment as ...
Medical Oncologist at Regional Cancer Care Associates, LLC I wonder if you are ready to give 6 or maybe 3 cyc...
Medical Oncologist at Novant Health Oncology Specialists @Aparna R. Parikh @Mark A. Lewis when do...
Answer from: Medical Oncologist at Academic Institution
I appreciate the cogent responses to my initial answer to the query above. Just to respond to a couple of the points raised:
If there were a tumor deposit in the original tumor specimen, then this would no longer be a stage II tumor, and I would certainly agree with the need for adjuvant chemothera...
Comments
Medical Oncologist at RWJBarnabas Health What about braf testing, seems like the ASCO book ...
I don't disagree with @Alfred I. Neugut but I do t...
I entirely agree with @Mark A. Lewis's comment as ...
I wonder if you are ready to give 6 or maybe 3 cyc...
@Aparna R. Parikh @Mark A. Lewis when do...